Evidence map›Paper›PMID 41195979›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2026

Longitudinal Associations Between Internalized HIV Stigma and Lower HIV Antiretroviral Therapy Adherence Among People With HIV.

Lydia N Drumright, Joseph A C Delaney, Timothy Crawford, Bridget M Whitney, Katerina Christopoulos, Edward Cachay, Kenneth H Mayer, Jeanne C Keruly, Geetanjali Chander, Mallory O Johnson and 8 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Lydia N DrumrightUniversity of Washington, Seattle, WA.ORCID 0000-0002-3361-8080
Joseph A C DelaneyUniversity of Washington, Seattle, WA.
Timothy CrawfordWright State University, Dayton, OH.
Bridget M WhitneyUniversity of Washington, Seattle, WA.
Katerina ChristopoulosUniversity of California, San Francisco, CA.
Edward CachayDepartment of Infectious Diseases, Mayo Clinic, Scottsdale, AZ.
Kenneth H MayerFenway Health, Harvard University, Boston, MA.
Jeanne C KerulyJohns Hopkins University, Baltimore, MD.
Geetanjali ChanderUniversity of Washington, Seattle, WA.
Mallory O JohnsonUniversity of California, San Francisco, CA.
George A YendewaCase Western Reserve University, Cleveland, OH.
Michael S SaagUniversity of Alabama, Birmingham, AI.
Mari M KitahataUniversity of Washington, Seattle, WA.
Richard D MooreJohns Hopkins University, Baltimore, MD.
Laura BamfordUniversity of California, San Diego, CA; and.
Sonia NapravnikUniversity of North Carolina, Chapel Hill, NC.
Rob J FredericksenUniversity of Washington, Seattle, WA.
Heidi M CraneUniversity of Washington, Seattle, WA.

Funding

3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)U01AA020793 · NIAAA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., LAU, BRYAN · 2011 to 2020
$5.8M
Substance use patterns and contexts: impact on epigenetic age and prevention strategies in an HIV clinical care cohortR01DA047045 · NIDA · UNIVERSITY OF WASHINGTON · PI Heidi M. Crane, Joseph Austin Delaney · 2018 to 2026
$5.1M
HIV and Aging Research Consortium (HARC)R33AG067069 · NIA · UNIVERSITY OF WASHINGTON · PI STEVEN N. AUSTAD, Heidi M. Crane · 2020 to 2026
$4.8M
Integration of Evidence-based Alcohol Interventions into HIV CareU01AA020802 · NIAAA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CROPSEY, KAREN L, MUGAVERO, MICHAEL J · 2011 to 2020
$4.2M
HIV and Substance Use Cohort Coordinating Center for Emerging and High Impact Scientific Cross Cohort Studies: HIV SUCCESSU24DA058307 · NIDA · UNIVERSITY OF WASHINGTON · PI GEETANJALI CHANDER, Heidi M. Crane · 2023 to 2026
$3.6M
Effectiveness of a smoking cessation algorithm integrated into HIV primary careR01DA044112 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CRANE, HEIDI M., CROPSEY, KAREN L · 2018 to 2022
$3.5M
1/4 Alcohol Research Consortium in HIV-Administrative Core (ARCH-AC)U24AA020801 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI CHANDER, GEETANJALI, MCCAUL, MARY E · 2011 to 2021
$3.5M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases P30AI027757Division of Intramural Research, National Institute of Allergy and Infectious Diseases P30AI027767Division of Intramural Research, National Institute of Allergy and Infectious Diseases P30AI050410Division of Intramural Research, National Institute of Allergy and Infectious Diseases P30AI094189Division of Intramural Research, National Institute of Allergy and Infectious Diseases R24AI067039NIAAA NIH HHS U01AA020793NIAAA NIH HHS U01AA020802NIAAA NIH HHS U24AA020801NIA NIH HHS R33AG067069NIDA NIH HHS R01DA044112NIDA NIH HHS R01DA047045NIDA NIH HHS U24 DA058307NIDA NIH HHS U24DA058307
6 · The paper itself

Abstract

backgroundInternalized HIV stigma (IHS) is associated with reductions in antiretroviral therapy (ART) adherence and HIV viremia mediated through depression. However, there is still a need to quantify the direct impact of IHS on ART adherence to inform interventions to improve medication adherence.

methodsThe Center for AIDS Research Network of Integrated Clinical Systems is a longitudinal, US-based, multisite cohort of people with HIV who complete patient-reported outcome assessments as part of HIV-care visits. Patient-reported outcome data include IHS items, ART adherence, depression assessments, substance use, and other outcomes. We examined associations between IHS and ART adherence using generalized linear latent and mixed models with a nonparametric random effects intercept to accommodate repeated measures. Results were compared with analyses using generalized estimating equations and marginal structural models.

resultsAmong 13,119 people with HIV, the mean age was 47.4 years, 17.6% were women, and 59.3% were non-White. Across 33,139 observations, controlled for repeated measures on individuals, HIV medication adherence was reduced by 1.07% for every point increase in IHS after controlling for age, sex, ethnicity, geographic location, and substance use, and 0.58% when additionally adjusted for depression score. Marginal structural models and generalized estimating equations provided similar results.

conclusionsOur study demonstrates that IHS has a direct association with reductions in ART adherence, which could affect other comorbid health outcomes that are influenced by unsuppressed viremia over time. Developing a thorough understanding of the mechanisms through which IHS affects ART adherence is critical for developing interventions to mitigate IHS and improve health outcomes across the lifespan.

Indexed as

Anti-HIV AgentsHIV InfectionsMedication AdherenceSocial StigmaAdultDepressionFemaleHumansLongitudinal StudiesMaleMiddle AgedAnti-HIV Agentsantiretroviral therapy adherenceCNICSdepressionpeople with HIVstigmasubstance use

Identifiers

PMID41195979
PMCPMC13143223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.